
Evidence-Based Medicine, Renin Inhibitors, Vasodilator Agents, Adrenergic beta-Antagonists, Angiotensin-Converting Enzyme Inhibitors, Blood Pressure, Diretrizes, Calcium Channel Blockers, Amides, Fumarates, RC666-701, Hypertension, Diseases of the circulatory (Cardiovascular) system, Humans, Diuretics, Adrenergic alpha-Antagonists, Antihypertensive Agents, Brazil
Evidence-Based Medicine, Renin Inhibitors, Vasodilator Agents, Adrenergic beta-Antagonists, Angiotensin-Converting Enzyme Inhibitors, Blood Pressure, Diretrizes, Calcium Channel Blockers, Amides, Fumarates, RC666-701, Hypertension, Diseases of the circulatory (Cardiovascular) system, Humans, Diuretics, Adrenergic alpha-Antagonists, Antihypertensive Agents, Brazil
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 10 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
